Elevated c-Src and c-Yes expression in malignant skin cancers

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Lee, Jang Hyun ^a   Pyon, Jae Kyung ^b   Kim, Dong Wook ^c   Lee, Sang Han ^c   Nam, Hae Seon ^c   Kim, Chul Han ^c   Kang, Sang Gue ^c   Lee, Yoon Jin ^c   Park, Mi Youn ^d   Jeong, Dong Jun ^c   Cho, Moon Kyun ^c  

^a Hanyang University Guri Hospital   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Soonchunhyang University   (South Korea)

^d National Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE YES; CSK PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; YES1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; ENZYMOLOGY; MIDDLE AGED; PATHOLOGY; SOUTH KOREA;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-YES; REPUBLIC OF KOREA; SKIN NEOPLASMS;

EID: 77955944269     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-116     Document Type: Article

References (18)

1. The epidemiology of skin cancer. HM Gloster DG Brodland, Dermatol Surg 1996 22 217 226 10.1016/1076-0512(95)00570-6 8599733
2. c-src 1. TJ O'Connor E Neufeld J Bechberger DJ Fujita, Cell Growth & Differentiation 1992 3 435 442
3. Cellular functions regulated by Src family kinases. SM Thomas JS Brugge, Annu Rev Cell Dev Biol 1997 13 513 609 10.1146/annurev.cellbio.13.1.513 9442882
4. c-src protein kinase activity in human tumor cell lines and tissues. N Rosen JB Bolen AM Schwartz P Cohen V DeSeau MA Israel, J Biol Chem 1986 261 13754 13759 3093483
5. c-src in human colon carcinoma and normal human colon mucosal cells. JB Bolen A Veillette AM Schwartz V Deseau N Rosen, Oncogene Res 1987 1 149 168 2453014 (Pubitemid 18072623)
6. c-src activity in well and poorly differentiated human colon carcinomas and cell lines. TK Weber G Steele IC Summerhayes, J Clin Invest 1992 90 815 821 10.1172/JCI115956 1381724
7. Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched non-tumor tissue. J Clement J Sanger A Berndt H Kosmehl FD Bohmer, J Cancer Res Clin Oncol 2001 127 226 230 10.1007/ s004320000197 11315256
8. Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells. W Hung B Elliott, J Biol Chem 2001 276 12395 12403 10.1074/jbc.M010715200 11278729
9. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. MD Planas-Silva RD Bruggeman RT Grenko JS Smith, Biochem Biophys Res Commun 2006 341 73 81 10.1016/j.bbrc.2005.12.164 16412380
10. Mislocalization of cell-cell adhesion complexs in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity. Y Zhao MD Planas-Silva, Cancer Letters 2009 275 204 212 10.1016/j.canlet.2008.10.022 19026486
11. Expression of the c-src Protooncogene in human skin tumors. A Barnekow E Paul M Schartl, Cancer Res 1987 47 235 240 2431764
12. Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines. AJ Eustace J Crown M Clynes N O'Donovan, J Transl Med 2008 6 53 10.1186/1479-5876-6-53 18823558
13. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. G Niu T Bowman M Huang S Shivers D Reintgen A Daud A Chang A Kraker R Jove H Yu, Oncogene 2002 21 7001 7010 10.1038/sj.onc.1205859 12370822
14. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. S Xi Q Zhang KF Dyer EC Lerner TE Smithgall WE Gooding J Kamens JR Grandis, J Biol Chem 2003 278 31574 31583 10.1074/jbc.M303499200 12771142
15. Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma. P Koppikar SH Choi AM Egloff Q Cai S Suzuki M Freilino H Nozawa SM Thomas WE Gooding JM Siegfried JR Grandis, Clin Cancer Res 2008 14 4284 4291 10.1158/1078-0432.CCR-07-5226 18594011
16. Combined inhibition of PLC-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion. H Nozawa G Howell S Suzuki Q Zhang Y Qi J Klein-Seetharaman A Wells JR Grandis SM Thomas, Clin Cancer Res 2008 14 4336 4344 10.1158/1078-0432.CCR-07-4857 18594017
17. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma. F Loganzo JS Dosik Y Zhao MJ Vidal DM Nanus M Sudol AP Albino, Oncogene 1993 8 2637 2644 7690926
18. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells. D Marchetti N Parikh M Sudol GE Gallick, Oncogne 1998 16 3253 3260 10.1038/sj.onc.1201877